AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31477161 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat 20 mg daily
Number of subjects: 240
Study 31477161 — intervention group
Group type: COMPARATOR
Intervention: Benzbromarone 25 mg daily
Number of subjects: 240
Study 29259061 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided physical exercise and dietary therapy
Number of subjects: 10
Study 26443050 — intervention group
Group type: EXPERIMENTAL
Intervention: Hallucinations
Number of subjects: 124
Study 26443050 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 124
Study 26443050 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug use
Number of subjects: 124
Study 26443050 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative symptoms
Number of subjects: 124
Study 26443050 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspiciousness/Persecution
Number of subjects: 124
Study 26443050 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety, Depression, and Hopelessness
Number of subjects: 124
Study 24028237 — intervention group
Group type: EXPERIMENTAL
Intervention: Message about health consequences of childhood obesity
Number of subjects: 2494
Study 24028237 — intervention group
Group type: EXPERIMENTAL
Intervention: Message about military readiness consequences of childhood obesity
Number of subjects: 2494
Study 24028237 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2494
Study 21719618 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 407
Study 21719618 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin
Number of subjects: 407
Study 21719618 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine plus gabapentin
Number of subjects: 407
Study 19539255 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 270
Study 19539255 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 270
Study 19539255 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 270
Study 16982294 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 750 mg QD for 5 days
Number of subjects: 369
Study 16982294 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate 875 mg/125 mg BID for 10 days
Number of subjects: 369
Study 16982294 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 369
Study 16982294 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate
Number of subjects: 369
Study 12740545 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisolv method
Number of subjects: 22
Study 12740545 — intervention group
Group type: COMPARATOR
Intervention: Rose-bur method
Number of subjects: 22
Study 11026118 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based examination
Number of subjects: 30
Study 11026118 — intervention group
Group type: COMPARATOR
Intervention: Paper-based examination
Number of subjects: 30
Study 9333066 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefodizime (single 2‐g intravenous dose)
Number of subjects: 42
Study 9333066 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (single 2‐g intravenous dose)
Number of subjects: 42
Study 8265839 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg q.d.s.)
Number of subjects: 77
Study 8265839 — intervention group
Group type: COMPARATOR
Intervention: Sodium cromoglycate (10 mg q.d.s.)
Number of subjects: 77
Study 3908417 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Hazard Appraisal (experimental counseled)
Number of subjects: 410
Study 3908417 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Hazard Appraisal (experimental uncounseled)
Number of subjects: 410
Study 3908417 — intervention group
Group type: COMPARATOR
Intervention: Control group (counseled)
Number of subjects: 410
Study 3908417 — intervention group
Group type: COMPARATOR
Intervention: Control group (uncounseled)
Number of subjects: 410
Study 30782982 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine with elbasvir-grazoprevir
Number of subjects: 26
Study 30782982 — intervention group
Group type: EXPERIMENTAL
Intervention: Doravirine with ledipasvir-sofosbuvir
Number of subjects: 26
Study 29250742 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatorsen + Prednisone
Number of subjects: 74
Study 29250742 — intervention group
Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 74
Study 26321218 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Alpha‐1 HC 100 mg
Number of subjects: 30
Study 26321218 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Alpha‐1 HC 200 mg
Number of subjects: 30
Study 26321218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 23890273 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: Pegylated interferon (160 μg weekly) + Ribavirin (1200 mg if ≥ 75 kg, 1000 mg if <75 kg) for 48 weeks
Number of subjects: 100
Study 23890273 — intervention group
Group type: COMPARATOR
Intervention: Group 2: Nitazoxanide (500 mg bid for 4 weeks lead-in) + Pegylated interferon + Ribavirin for 48 weeks
Number of subjects: 100
Study 22339573 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolofylline 30 mg
Number of subjects: 2002
Study 22339573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2002
Study 20357761 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 22
Study 20357761 — intervention group
Group type: COMPARATOR
Intervention: Valproic acid (VPA)
Number of subjects: 22
Study 20357761 — intervention group
Group type: COMPARATOR
Intervention: Healthy comparison subjects
Number of subjects: 22
Study 18287126 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine 5′-monophosphate (AMP)
Number of subjects: 36
Study 18287126 — intervention group
Group type: COMPARATOR
Intervention: Methacholine (MCh)
Number of subjects: 36
Study 18287126 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 36
Study 16599102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive nutrition education (INE) twice a week for three months
Number of subjects: 282
Study 16599102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive nutrition education with supplementary feeding (INE+SF) twice a week for three months
Number of subjects: 282
Study 16599102 — intervention group
Group type: COMPARATOR
Intervention: Standard routine nutrition education from community nutrition promoters twice a month
Number of subjects: 282
Study 16599102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive nutrition education (INE)
Number of subjects: 282
Study 16599102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive nutrition education with supplementary feeding (INE+SF)
Number of subjects: 282
Study 16599102 — intervention group
Group type: COMPARATOR
Intervention: Standard routine nutrition education
Number of subjects: 282
Study 16599102 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention groups (INE and INE+SF)
Number of subjects: 282
Study 11811507 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Number of subjects: 20
Study 9732938 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual therapy: Lansoprazole (30 mg b.i.d.) and Amoxicillin (1 g b.i.d.)
Number of subjects: 50
Study 9732938 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy: Lansoprazole (30 mg b.i.d.), Amoxicillin (1 g b.i.d.), and Clarithromycin (500 mg b.i.d.)
Number of subjects: 50
Study 7964858 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg treatment
Number of subjects: 0
Study 7964858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2525998 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 50 mg + Hydrochlorothiazide 25 mg (group A)
Number of subjects: 40
Study 2525998 — intervention group
Group type: COMPARATOR
Intervention: Amiloride 5 mg + Hydrochlorothiazide 50 mg (group B)
Number of subjects: 40
Study 12608175 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet
Number of subjects: 17
Study 12608175 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 17
Study 31937614 — intervention group
Group type: EXPERIMENTAL
Intervention: Radium-223 plus enzalutamide (RE)
Number of subjects: 39
Study 31937614 — intervention group
Group type: COMPARATOR
Intervention: Enzalutamide alone
Number of subjects: 39
Study 30730356 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples-based intervention including one group session (3-4 hours) and 4 counseling sessions (1-2 hours) focusing on communication skills, intimate partner violence, and HIV prevention.
Number of subjects: 334
Study 30730356 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 334
Study 27855739 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyvinylidene fluoride (PVDF) belts
Number of subjects: 50
Study 27855739 — intervention group
Group type: COMPARATOR
Intervention: Respiratory inductance plethysmography (RIP) belts
Number of subjects: 50
Study 24997175 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted education strategies to increase delivery of early enteral nutrition
Number of subjects: 121
Study 24997175 — intervention group
Group type: COMPARATOR
Intervention: Standard ad hoc practice
Number of subjects: 121
Study 23299978 — intervention group
Group type: EXPERIMENTAL
Intervention: LHW intervention addressing HBV
Number of subjects: 250
Study 23299978 — intervention group
Group type: COMPARATOR
Intervention: LHW intervention addressing physical activity
Number of subjects: 250
Study 21967302 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfluidic platforms for compartmentalization of neurons
Number of subjects: 0
Study 21967302 — intervention group
Group type: COMPARATOR
Intervention: Traditional methods for compartmentalization
Number of subjects: 0
Study 21967302 — intervention group
Group type: EXPERIMENTAL
Intervention: Compartmentalized microfluidic platforms
Number of subjects: 0
Study 21967302 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological manipulation and electrical stimulation of synapses
Number of subjects: 0
Study 18331175 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar sealer device
Number of subjects: 50
Study 18331175 — intervention group
Group type: COMPARATOR
Intervention: Standard electrocautery
Number of subjects: 50
Study 16823832 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pedicle occlusion with ischaemic interval of 15 minutes (SG)
Number of subjects: 108
Study 16823832 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pedicle occlusion with ischaemic interval of 30 minutes (PG)
Number of subjects: 108
Study 12624286 — intervention group
Group type: EXPERIMENTAL
Intervention: NAA concentration in the symptomatic hemisphere
Number of subjects: 19
Study 12624286 — intervention group
Group type: COMPARATOR
Intervention: NAA concentration in the contralateral hemisphere
Number of subjects: 19
Study 12624286 — intervention group
Group type: COMPARATOR
Intervention: NAA concentration in control subjects
Number of subjects: 19
Study 12624286 — intervention group
Group type: EXPERIMENTAL
Intervention: NAA concentration in patients with cerebral ischemia (symptomatic hemisphere)
Number of subjects: 19
Study 12624286 — intervention group
Group type: COMPARATOR
Intervention: NAA concentration in patients with cerebral ischemia (asymptomatic hemisphere)
Number of subjects: 19
Study 11083348 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-week exercise program to improve aerobic capacity, muscular endurance, and flexibility.
Number of subjects: 258
Study 11083348 — intervention group
Group type: COMPARATOR
Intervention: Control group (individuals not treated for chronic pain)
Number of subjects: 258
Study 8803642 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (enoxaparin 40 mg once daily)
Number of subjects: 78
Study 8803642 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg once daily) plus graduated elastic compression (TEDR stockings) for 8-12 days
Number of subjects: 78
Study 8803642 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo injections)
Number of subjects: 78
Study 8803642 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with DVT
Number of subjects: 78
Study 8803642 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without DVT
Number of subjects: 78
Study 1387231 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g fish oil preparation
Number of subjects: 0
Study 1387231 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g fish oil preparation
Number of subjects: 0
Study 1387231 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g fish oil preparation
Number of subjects: 0
Study 1387231 — intervention group
Group type: EXPERIMENTAL
Intervention: High dosages of fish oil
Number of subjects: 0
Study 1387231 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dosages of fish oil
Number of subjects: 0
Study 1387231 — intervention group
Group type: EXPERIMENTAL
Intervention: Both fish oil preparations
Number of subjects: 0
Study 6436897 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 16 mg per day (low dose)
Number of subjects: 48
Study 6436897 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol 80 mg per day (high dose)
Number of subjects: 48
Study 6436897 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study 31965532 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-managed, CBT-oriented exposure training delivered by the primary care practice team
Number of subjects: 419
Study 31965532 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 419
Study 29423774 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose levels above the median (11.5 mmol/L)
Number of subjects: 513
Study 29423774 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with diabetes
Number of subjects: 513
Study 26616224 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 175 mg/m2 administered over a 3 hour infusion, cycling every 21 days
Number of subjects: 31
Study 25012645 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (group A)
Number of subjects: 60
Study 25012645 — intervention group
Group type: COMPARATOR
Intervention: Passive physical therapy (group B)
Number of subjects: 60
Study 23959190 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV biofeedback
Number of subjects: 45
Study 23959190 — intervention group
Group type: COMPARATOR
Intervention: Autogenic Training (AT)
Number of subjects: 45
Study 23959190 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 45
Study 20625187 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushed ice ingestion (ICE)
Number of subjects: 7
Study 20625187 — intervention group
Group type: COMPARATOR
Intervention: Tap water (CON)
Number of subjects: 7
Study 18619799 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fiber therapy
Number of subjects: 193
Study 18619799 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 193
Study 15944853 — intervention group
Group type: EXPERIMENTAL
Intervention: Forensic patients
Number of subjects: 79
Study 15944853 — intervention group
Group type: COMPARATOR
Intervention: General psychiatric patients
Number of subjects: 79
Study 14735032 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy (Group I)
Number of subjects: 113
Study 14735032 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group II)
Number of subjects: 113
Study 10231050 — intervention group
Group type: EXPERIMENTAL
Intervention: Fallopian sperm perfusion
Number of subjects: 0
Study 10231050 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine insemination (IUI)
Number of subjects: 0
Study 10231050 — intervention group
Group type: EXPERIMENTAL
Intervention: Fallopian sperm perfusion (meta-analysis)
Number of subjects: 0
Study 8910627 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐16 virus‐like particles (VLP)
Number of subjects: 0
Study 8910627 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐16 E6 and E7 proteins
Number of subjects: 0
Study 8910627 — intervention group
Group type: EXPERIMENTAL
Intervention: Any antigen preparation
Number of subjects: 0
Study 8910627 — intervention group
Group type: EXPERIMENTAL
Intervention: High antibody titers
Number of subjects: 0
Study 1869332 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiographic monitoring
Number of subjects: 40
Study 1869332 — intervention group
Group type: COMPARATOR
Intervention: No echocardiographic monitoring
Number of subjects: 40
Study 6873561 — intervention group
Group type: EXPERIMENTAL
Intervention: Propantheline bromide (anticholinergic agent)
Number of subjects: 10
Study 2579597 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraderma injection of terbutaline (0.25-100 ng)
Number of subjects: 38
Study 2579597 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral terbutaline and theophylline treatment
Number of subjects: 38
Study 2579597 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 38
Study 28720423 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-Based Teaching (CBT)
Number of subjects: 96
Study 28720423 — intervention group
Group type: COMPARATOR
Intervention: Bedside Teaching
Number of subjects: 96
Study 27473676 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer counseling intervention promoting exclusive breastfeeding (EBF) in addition to standard care
Number of subjects: 765
Study 27473676 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care only)
Number of subjects: 765
Study 27473676 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer counseling intervention promoting EBF
Number of subjects: 765
Study 23991679 — intervention group
Group type: EXPERIMENTAL
Intervention: 1‐hour therapeutic play intervention plus routine care
Number of subjects: 106
Study 23991679 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 106
Study 22849416 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind lineup administration (presumed blind condition)
Number of subjects: 0
Study 22849416 — intervention group
Group type: COMPARATOR
Intervention: Non-blind lineup administration (presumed nonblind condition)
Number of subjects: 0
Study 22849416 — intervention group
Group type: EXPERIMENTAL
Intervention: Inaccurate participants in presumed blind condition
Number of subjects: 0
Study 21122147 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold-pressed turnip rapeseed oil (CPTRO)
Number of subjects: 37
Study 21122147 — intervention group
Group type: COMPARATOR
Intervention: Butter
Number of subjects: 37
Study 18780885 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint-induced movement therapy (CIMT)
Number of subjects: 30
Study 18780885 — intervention group
Group type: COMPARATOR
Intervention: Control group (CIMT after 4 months)
Number of subjects: 30
Study 18780885 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (CIMT immediately after baseline)
Number of subjects: 30
Study 15733876 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft forceps
Number of subjects: 96
Study 15733876 — intervention group
Group type: COMPARATOR
Intervention: Regular forceps
Number of subjects: 96
Study 14520027 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-modified diet with caloric restriction and daily intake of 35-50 g oat bran
Number of subjects: 235
Study 14520027 — intervention group
Group type: COMPARATOR
Intervention: Fat-modified, oat bran-free diet with caloric restriction
Number of subjects: 235
Study 14520027 — intervention group
Group type: COMPARATOR
Intervention: Control group (53 male overweight but normocholesterolemic subjects)
Number of subjects: 235
Study 10655911 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% sevoflurane in nitrous oxide and oxygen
Number of subjects: 64
Study 10655911 — intervention group
Group type: COMPARATOR
Intervention: Propofol 3-4 mg kg-1 with succinylcholine 2 mg kg-1
Number of subjects: 64
Study 10655911 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 64
Study 10655911 — intervention group
Group type: COMPARATOR
Intervention: Propofol-succinylcholine
Number of subjects: 64
Study 8887260 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 929
Study 8887260 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone in combination with other immunosuppressants
Number of subjects: 929
Study 8887260 — intervention group
Group type: COMPARATOR
Intervention: Various treatment protocols
Number of subjects: 929
Study 1649265 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating regimen of methotrexate, etoposide, and cisplatin
Number of subjects: 170
Study 1649265 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with cyclophosphamide, doxorubicin, and vincristine (CAV)
Number of subjects: 170
Study 6226963 — intervention group
Group type: EXPERIMENTAL
Intervention: Amineptine
Number of subjects: 38
Study 6226963 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 38
Study 30836957 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention focusing on improving physical activity, including access to a gym, motivational counselling, and organized lunch walks.
Number of subjects: 330
Study 30836957 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention focusing on reducing sedentary behavior, including standing- and walking meetings, motivational counselling, and encouragement to reduce sitting.
Number of subjects: 330
Study 30836957 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (passive control) that will receive the allocated intervention after a 6-month delay.
Number of subjects: 330
Study 30836957 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions include 5 sessions of motivational counselling.
Number of subjects: 330
Study 30836957 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions include measurements of cardiovascular fitness, body composition, sleep, self-reported physical activity and sedentary behavior, and other health habits.
Number of subjects: 330
Study 30188085 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling (involving peer counsellors)
Number of subjects: 237
Study 30188085 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-economic development (SED)
Number of subjects: 237
Study 30188085 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact between community members and affected people
Number of subjects: 237